Fred Hutchinson receives $9.7 million to lead early detection consortium
SEATTLE The National Cancer Institute (NCI), part of the National Institutes of Health, has announced that SAIC-Frederick Inc.* has made two-year awards, under a competitive solicitation, totaling $13.4 million to two research teams from 10 cancer-research institutions. Scientists from Fred Hutchinson Cancer Research Center will lead one of the research teams; scientists from the University of M...Fred Hutchinson uses IBM technology to help find genetic links to immune-system diseases
Fred Hutchinson Cancer Research Center today announced that its researchers are using IBM technology to help discover why some people are more susceptible than others to infectious and autoimmune diseases, such as leukemia and AIDS. The research also seeks answers to medical mysteries such as why vaccines protect some individuals better than others and why some close donor-recipient transplants...Fred Hutchinson Cancer Research Center study shows retinoids kill childhood brain tumor cells
Researchers find that vitamin A derivatives may be highly effective and minimally toxic treatments for medulloblastoma, the most common form of childhood brain cancer. Clinical trials of the drugs, known as retinoids, are being planned for children who are at high risk for tumor relapse following standard therapy.... ...A study led by Fred Hutchinson researchers, Drs. Andrew Hallahan and James O...Fred Hutchinson oversees two grants of nearly $8 million to develop blood test for breast cancer
The Fred Hutchinson Cancer Research Center will oversee two major grants totaling nearly $8 million to develop a blood test that can be used in conjunction with mammography to improve early detection of breast cancer. ...The first, a $7 million, four-year Breast Cancer Center of Excellence grant to Fred Hutchinson from the U.S. Department of Defense, will involve investigators from 10 institution...Fred Hutchinson Research Center awarded $7 million grant
WHITE PLAINS, N.Y. (October 2, 2002) - The Leukemia & Lymphoma Society (the Society) announced it has awarded a $7 million grant through its Specialized Center of Research (SCOR) program to Dr. Irwin Bernstein, head of pediatric oncology research at the Fred Hutchinson Cancer Research Center in Seattle. Dr. Bernstein will accept the award in Washington, D.C. at the Society's Journey of Hope Rese...Fred Hutchinson receives $12.7 million to lead prostate-cancer consortium
The National Cancer Institute, a branch of the National Institutes of Health, has awarded $12.7 million to the Fred Hutchinson Cancer Research Center to lead a multi-center, five-year investigation into the genetic mechanisms of prostate-cancer progression. Understanding how and why prostate cancer can turn deadly is key to developing therapies that may effectively treat men with recurrent or adv...Hutchinson Center receives $1.2 million from National Science Foundation to study plant genetics
.The Fred Hutchinson Cancer Research Center has received a $1.2 million first-year grant from the National Science Foundation to implement a new strategy for obtaining plants with desirable genetic mutations. The strategy, called TILLING, will be applied to genes of Arabidopsis thaliana, a small flowering member of the mustard family used as a model system for plant genetic studies.. Using the T...Of vasectomies, vitamins and prostate-cancer risk: Hutchinson Center study examines the links
...For men concerned about prostate-cancer risk, here's some good news from...researchers at the Fred Hutchinson Cancer Research Center in Seattle: ... vasectomy does not increase a man's risk of prostate cancer, contrary to...several earlier studies that have suggested a link; and... dietary supplementation with zinc, vitamin C or vitamin E may significantly...reduce the risk of the disease.....Seattle -- Researchers at the Fred Hutchinson Cancer Research Center (FHCRC), the.University of Washington (UW) and Targeted Genetics Corp. (Nasdaq:TGEN) announce.the publication of data from a Phase I study evaluating a new concept in the.therapy of HIV-1 infection. The paper ,titled "In vivo Migration and Function of.Transferred HIV-1 Specific Cytotoxic T Cells," appears in the current issue...